Milestone Pharmaceuticals Inc
MIST1.920USD
-0.030-1.54%
收盘 09/19, 16:00（美东）报价延迟15分钟
102.71M总市值
亏损市盈率 TTM
关于 Milestone Pharmaceuticals Inc 公司
Milestone Pharmaceuticals Inc. 是一家总部位于加拿大的生物制药公司。该公司专注于心血管药物的开发和商业化。其主要候选产品依曲帕米是一种强效速效钙通道阻滞剂，该公司设计并正在开发一种速效鼻喷雾剂，供患者使用。该公司还专注于开发依曲帕米用于治疗阵发性室上性心动过速 (PSVT)，随后用于治疗心房颤动伴快速心室率 (AFib-RVR) 和其他心血管适应症。
公司简介
公司代码MIST
公司名称Milestone Pharmaceuticals Inc
上市日期May 09, 2019
CEOMr. Joseph Oliveto
员工数量33
证券类型Ordinary Share
年结日May 09
公司地址420-1111 boul. Dr.-Frederik-Philips
城市MONTREAL
上市交易所NASDAQ Global Select Consolidated
国家Canada
邮编H4M 2X6
电话15143360444
网址https://www.milestonepharma.com
公司代码MIST
上市日期May 09, 2019
CEOMr. Joseph Oliveto
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
78.45K
+212.30%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
69.20K
+260.35%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
+333.33%
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
--
Mr. Stuart Duty
Mr. Stuart Duty
Independent Director
Independent Director
--
--
Mr. Joeseph C. Papa
Mr. Joeseph C. Papa
Independent Director
Independent Director
--
--
Mr. Andrew Saik
Mr. Andrew Saik
Independent Director
Independent Director
--
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
--
--
Mr. Joseph Oliveto
Mr. Joseph Oliveto
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Lorenz Muller
Mr. Lorenz Muller
Chief Commercial Officer
Chief Commercial Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
78.45K
+212.30%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
69.20K
+260.35%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
+333.33%
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
--
Mr. Stuart Duty
Mr. Stuart Duty
Independent Director
Independent Director
--
--
Mr. Joeseph C. Papa
Mr. Joeseph C. Papa
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 9月13日 周六
更新时间: 9月13日 周六
持股股东
股东类型
持股股东
持股股东
占比
Trails Edge Capital Partners LP
6.27%
Oliveto (Joseph Gerard)
2.95%
RTW Investments L.P.
2.95%
Propel Bio Management, LLC
2.11%
Alta Fundamental Advisers LLC
1.65%
其他
84.07%
持股股东
持股股东
占比
Trails Edge Capital Partners LP
6.27%
Oliveto (Joseph Gerard)
2.95%
RTW Investments L.P.
2.95%
Propel Bio Management, LLC
2.11%
Alta Fundamental Advisers LLC
1.65%
其他
84.07%
股东类型
持股股东
占比
Investment Advisor
10.40%
Individual Investor
3.61%
Investment Advisor/Hedge Fund
3.03%
Hedge Fund
2.31%
Venture Capital
2.30%
Research Firm
2.16%
Bank and Trust
0.02%
其他
76.18%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
99
14.54M
18.86%
-15.65M
2025Q1
102
12.26M
22.94%
-17.24M
2024Q4
99
25.17M
47.19%
-9.38M
2024Q3
113
29.31M
55.02%
-13.44M
2024Q2
115
30.81M
57.87%
-11.80M
2024Q1
116
31.96M
60.43%
+3.19M
2023Q4
112
18.49M
55.02%
-13.59M
2023Q3
109
20.24M
60.32%
-12.06M
2023Q2
108
21.35M
63.87%
-11.78M
2023Q1
110
22.19M
66.58%
-11.98M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Oliveto (Joseph Gerard)
2.44M
4.57%
+2.16M
+756.94%
Apr 15, 2025
RTW Investments L.P.
2.51M
4.69%
--
--
Mar 31, 2025
Propel Bio Management, LLC
1.45M
2.71%
+1.25M
+625.78%
Mar 31, 2025
Alta Fundamental Advisers LLC
1.43M
2.67%
-1.23M
-46.31%
Mar 31, 2025
BML Capital Management LLC
1.14M
2.13%
--
--
Mar 31, 2025
Simplify Asset Management Inc
850.00K
1.59%
+850.00K
--
Mar 31, 2025
Morgan Stanley & Co. LLC
965.92K
1.81%
-320.62K
-24.92%
Mar 31, 2025
TD Securities, Inc.
750.00K
1.4%
--
--
Mar 31, 2025
Lion Point Capital, L.P.
548.81K
1.03%
-477.00K
-46.50%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
